Atrial Fibrillation Trial, Recruiting NCT06698159 Sponsor: Hospital Universitario 12 de Octubre Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT06698159
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are over 18 years old.
  • People who have been diagnosed with a type of irregular heart rhythm called atrial fibrillation (either the "comes and goes" type or the ongoing type) within the last 2 years.
  • People whose doctor has recommended a specific heart procedure that uses a balloon and freezing technology to treat the irregular heart rhythm.

Who may not be able to join:

  • People whose left heart chamber (left atrium) is significantly enlarged beyond certain size measurements.
  • People who have previously had a catheter-based or surgical procedure to treat atrial fibrillation.
  • People who are considered severely frail (scoring 7 or higher on a standard frailty scale) or who have a life expectancy of less than 1 year.
  • People who are unable to understand the study or cannot give their agreement to take part.
  • People whose procedure would require additional freezing treatments in the heart beyond the standard areas (pulmonary veins).
  • People whose procedure would require an additional catheter (a thin flexible tube) beyond the standard cryoablation device to complete the treatment.
  • People who cannot safely take blood-thinning medication, or who have a known intolerance to a specific blood thinner called heparin.
  • People who have a blood clot present inside their heart.
  • People whose atrial fibrillation is caused by a temporary or reversible condition.
  • People who have serious disease affecting the mitral or aortic heart valves.
  • People who have a heart condition they were born with.
  • People who are pregnant or planning to become pregnant within the next 12 months.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 659385591

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Hospital Universitario 12 de Octubre
Registry
ClinicalTrials.gov
Start date
1 November 2024
Est. completion
1 May 2026

Where this trial is recruiting

🇮🇹 Italy 🇪🇸 Spain

Primary endpoints

Recurrence of atrial tachyarrhythmia; Arrhythmic load; Arrhythmic load

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov